Stronger Prognostic Power of the CpG Island Methylator Phenotype than Methylation of Individual Genes in Neuroblastomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Stronger Prognostic Power of the CpG Island Methylator Phenotype than Methylation of Individual Genes in Neuroblastomas

Published:2013-04-25 Issue:6 Volume:43 Page:641-645
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Asada Kiyoshi,Watanabe Naoko,Nakamura Yohko,Ohira Miki,Westermann Frank,Schwab Manfred,Nakagawara Akira,Ushijima Toshikazu

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/43/6/641/16835662/hyt058.pdf

Reference24 articles.

1. Neuroblastoma;Maris;Lancet,2007

2. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas;Abe;Cancer Res,2005

3. Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas;Abe;Cancer Lett,2007

4. A pyrosequencing assay for the quantitative methylation analysis of the PCDHB gene cluster, the major factor in neuroblastoma methylator phenotype;Banelli;Lab Invest,2011

5. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour;Schwab;Nature,1983

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic Dysregulation in MYCN-Amplified Neuroblastoma;International Journal of Molecular Sciences;2023-12-03

2. MYCN in Neuroblastoma: “Old Wine into New Wineskins”;Diseases;2021-10-29

3. Association of RASSF1A, DCR2, and CASP8 Methylation with Survival in Neuroblastoma: A Pooled Analysis Using Reconstructed Individual Patient Data;BioMed Research International;2020-12-15

4. Hypermethylation status of DAPK, MGMT and RUNX3 in HPV negative oral and oropharyngeal squamous cell carcinoma;Genetics and Molecular Biology;2020

5. Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary;Nature Reviews Clinical Oncology;2017-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3